Abdulghani H Al-Saeed1, Maria I Constantino2, Lynda Molyneaux3, Mario D'Souza4, Franziska Limacher-Gisler5, Connie Luo6, Ted Wu6, Stephen M Twigg3, Dennis K Yue3, Jencia Wong3. 1. Diabetes Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia Riyadh Military Hospital, Riyadh, Kingdom of Saudi Arabia Discipline of Medicine, University of Sydney, Sydney, NSW, Australia. 2. Diabetes Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia Discipline of Medicine, University of Sydney, Sydney, NSW, Australia maria.constantino@sydney.edu.au. 3. Diabetes Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia Discipline of Medicine, University of Sydney, Sydney, NSW, Australia. 4. Clinical Research Centre, Sydney Local Health District, Sydney, NSW, Australia. 5. Discipline of Medicine, University of Sydney, Sydney, NSW, Australia. 6. Diabetes Centre, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Abstract
OBJECTIVE: This study compared the prevalence of complications in 354 patients with T2DM diagnosed between 15 and 30 years of age (T2DM15-30) with that in a duration-matched cohort of 1,062 patients diagnosed between 40 and 50 years (T2DM40-50). It also examined standardized mortality ratios (SMRs) according to diabetes age of onset in 15,238 patients covering a wider age-of-onset range. RESEARCH DESIGN AND METHODS: Complication status was assessed according to a standard protocol and extracted from our electronic database. Survival status was ascertained by data linkage with the Australian National Death Index. SMRs were calculated in comparison with the background Australian population and analyzed according to age of onset. RESULTS: After matching for duration, despite their younger age, T2DM15-30 had more severe albuminuria (P = 0.004) and neuropathy scores (P = 0.003). T2DM15-30 were as commonly affected by metabolic syndrome factors as T2DM40-50 but less frequently treated for hypertension and dyslipidemia (P < 0.0001). An inverse relationship between age of diabetes onset and SMR was seen, which was the highest for T2DM15-30 (3.4 [95% CI 2.7-4.2]). SMR plots adjusting for duration show that for those with T2DM15-30, SMR is the highest at any chronological age, with a peak SMR of more than 6 in early midlife. In contrast, mortality for older-onset groups approximates that of the background population. CONCLUSIONS: The negative effect of diabetes on morbidity and mortality is greatest for those diagnosed at a young age compared with T2DM of usual onset. These results highlight the growing imperative to direct attention toward young-onset T2DM and for effective interventions to be applied before middle age.
OBJECTIVE: This study compared the prevalence of complications in 354 patients with T2DM diagnosed between 15 and 30 years of age (T2DM15-30) with that in a duration-matched cohort of 1,062 patients diagnosed between 40 and 50 years (T2DM40-50). It also examined standardized mortality ratios (SMRs) according to diabetes age of onset in 15,238 patients covering a wider age-of-onset range. RESEARCH DESIGN AND METHODS: Complication status was assessed according to a standard protocol and extracted from our electronic database. Survival status was ascertained by data linkage with the Australian National Death Index. SMRs were calculated in comparison with the background Australian population and analyzed according to age of onset. RESULTS: After matching for duration, despite their younger age, T2DM15-30 had more severe albuminuria (P = 0.004) and neuropathy scores (P = 0.003). T2DM15-30 were as commonly affected by metabolic syndrome factors as T2DM40-50 but less frequently treated for hypertension and dyslipidemia (P < 0.0001). An inverse relationship between age of diabetes onset and SMR was seen, which was the highest for T2DM15-30 (3.4 [95% CI 2.7-4.2]). SMR plots adjusting for duration show that for those with T2DM15-30, SMR is the highest at any chronological age, with a peak SMR of more than 6 in early midlife. In contrast, mortality for older-onset groups approximates that of the background population. CONCLUSIONS: The negative effect of diabetes on morbidity and mortality is greatest for those diagnosed at a young age compared with T2DM of usual onset. These results highlight the growing imperative to direct attention toward young-onset T2DM and for effective interventions to be applied before middle age.
Authors: Petter Bjornstad; Lori Laffel; Jane Lynch; Laure El Ghormli; Ruth S Weinstock; Sherida E Tollefsen; Kristen J Nadeau Journal: Diabetes Care Date: 2019-04-09 Impact factor: 19.112
Authors: Omar Silverman-Retana; Adam Hulman; Jannie Nielsen; Claus T Ekstrøm; Bendix Carstensen; Rebecca K Simmons; Lasse Bjerg; Luke W Johnston; Daniel R Witte Journal: Diabetologia Date: 2020-02-19 Impact factor: 10.122
Authors: Thomas R Hird; Ella Zomer; Alice Owen; Lei Chen; Zanfina Ademi; Dianna J Magliano; Danny Liew Journal: Diabetologia Date: 2019-04-27 Impact factor: 10.122
Authors: Dana Dabelea; Jeanette M Stafford; Elizabeth J Mayer-Davis; Ralph D'Agostino; Lawrence Dolan; Giuseppina Imperatore; Barbara Linder; Jean M Lawrence; Santica M Marcovina; Amy K Mottl; Mary Helen Black; Rodica Pop-Busui; Sharon Saydah; Richard F Hamman; Catherine Pihoker Journal: JAMA Date: 2017-02-28 Impact factor: 56.272
Authors: Thomas H Inge; Lori M Laffel; Todd M Jenkins; Marsha D Marcus; Natasha I Leibel; Mary L Brandt; Morey Haymond; Elaine M Urbina; Lawrence M Dolan; Philip S Zeitler Journal: JAMA Pediatr Date: 2018-05-01 Impact factor: 16.193
Authors: Petter Bjornstad; Kara Hughan; Megan M Kelsey; Amy S Shah; Jane Lynch; Edward Nehus; Mark Mitsnefes; Todd Jenkins; Peixin Xu; Changchun Xie; Thomas Inge; Kristen Nadeau Journal: Diabetes Care Date: 2019-11-04 Impact factor: 19.112
Authors: Petter Bjornstad; Edward Nehus; Todd Jenkins; Mark Mitsnefes; Marva Moxey-Mims; John B Dixon; Thomas H Inge Journal: Kidney Int Date: 2020-02-03 Impact factor: 10.612